The company is developing new molecules for the treatment of Traumatic Brain Injury and stroke, and a diagnostic tool based on biomarkers.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free